In the overall intent-to-treat (ITT) population, the PFS difference was smaller and did not reach statistical significance (3.8 months vs. 3.6 months; HR, 0.83; p = 0.07).
← all excerpts
Research Progress of PROTACs in Breast Cancer: Subtype-Oriented Target Landscape, Clinical Stratification Evidence, and Engineering Strategies for Translation.
1
0.0700
0.0700